Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

María Asunción Esteve‐Pastor, Francisco Marı́n, Vanessa Roldán et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022

Cited by 16